Choose Your Words Carefully: Inventors Are Masters of Their Claims, and the Words They Use to Describe and Claim Their Invention Control
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
BIO-RAD LABORATORIES, INC. v. ITC
Before Newman, Lourie, and Dyk. Appeal from the ITC.
Summary: Patentees cannot escape the bounds of their claims by promoting oversimplified characterizations of those claims.
Bio-Rad brought an ITC action against 10X Genomics over the importation of certain microfluidic chips. The ITC found that some 10X products infringed Bio-Rad asserted patents, and both parties appealed. Among other issues, Bio-Rad argued on appeal that because the structural limitations recited in its claims are all included in 10X’s products, the ITC should have found infringement of all asserted patents.
The Federal Circuit affirmed the ITC after finding that Bio-Rad’s structural limitations argument was premised on rewriting the claims in an oversimplified form and removing all limitations that differentiate the recited structures from each other. The Federal Circuit stated that the inventors chose to characterize the invention based on its materials, not structure, and that Bio-Rad could not escape that choice by pointing to the general proposition of law that “apparatus claims cover what a device is, not what a device does.” The Federal Circuit noted that it would be improper to disregard almost all of the words of the claim simply because the claim limitations are structural.
Editor: Paul Stewart
Written by: Hans L. Mayer
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…